The Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 30-Jun-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
NSE has asked Lotus Eye Hospital and Institute to clarify why segment details were not submitted along with its Q1 FY26 (quarter ended 30 June 2025) financial results, as required under Regulation 33 of SEBI's Listing Obligations and Disclosure Requirements. The company has not yet responded to the exchange's query. This is a procedural compliance-related clarification request and does not indicate any financial irregularity at this stage. The company's reply is awaited and will likely be filed shortly as a clarification on the BSE/NSE platform.
This is a routine exchange query on disclosure compliance and is unlikely to materially affect the stock price. Investors should wait for the company's response to confirm there are no underlying issues with the reported financials.